Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine

American Journal of Pathology

Volumn 153, Issue 1, 1998, Pages 319-329

  Laconi, Ezio ^a   Oren, Ran ^b,c   Mukhopadhyay, Deb K ^b,c   Hurston, Ethel ^b,c   Laconi, Sergio ^a   Pani, Paolo ^a   Dabeva, Mariana D ^b,c   Shafritz, David A ^b,c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b MARION BESSIN LIVER RESEARCH CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRROLIZIDINE ALKALOID; RETRORSINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSPLANTATION; EXPERIMENTAL TRANSPLANTATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0031870235     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65574-5     Document Type: Article

References (36)

1. Gupta S, Roy Chowdhury J: Hepatocyte transplantation, back to the future. Hepatology 1992, 15:156-162
2. Wilson JM: Round two for liver gene therapy. Nat Genet 1996, 12: 232-233
3. Roy Chowdhury J, Grossmann M, Gupta S, Roy Chowdhury N, Baker JR Jr, Wilson JM: Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991, 254:1802-1805
4. Grossmann M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ, Wilson JM: Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994, 6:335-341
5. Zhang H, Miescher-Clemens E, Drugas G, Lee SM, Colombani P: Intrahepatic hepatocyte transplantation following subtotal hepatectomy in the recipient: a possible model in the treatment of hepatic enzyme deficiency. J Pediatr Surg 1992, 27:312-315
6. Kokudo N, Ohashi K, Takahashi S, Bandai Y, Sanjo K, Idezuki Y, Nozawa M: Effect of 70% hepatectomy on DNA synthesis in rat hepatocyte isograft into the spleen. Transplant Proc 1994, 26:3464-3465
7. Borel Rinkes IH, Bijma A, Kazemier G, Sinaasappel M, Valerio D, Terpatra OT: Proliferative response of hepatocytes transplanted into spleen or solid support. J Surg Res 1994, 56:417-423
8. Bucher NLR, Swaffield MN: The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res 1964, 240:1611-1625
9. Rabes HM, Wirshing R, Tuczek H-V, Iseler G: Analysis of cell cycle compartments of hepatocytes after partial hepatectomy. Cell Tissue Kinet 1976, 9:517-532
10. Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S: Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology 1996, 23:482-496
11. Rozga J, Holtzman M, Moscioni AD, Fujioka H, Morsiani E, Demetriou AA: Repeated intraportal hepatocyte transplantation in analbumin-emic rats. Cell Transplant 1995, 4:237-243
12. Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S: Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology 1996, 111:1092-1102
13. Vranken Peeter M-JTD, Patijin GA, Lieber A, Perkins J, Kay MA: Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 1997, 25:884-888
14. Sandgren EP, Palmiter RD, Heckel JL, Dougherty CC, Brinster RL, Degen JL: Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991, 66:245-256
15. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL: Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994, 263:1149-1152
16. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL: Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA 1995, 92:4942-4946
17. Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou C-N, Finegold M, Grompe M: Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. Nat Genet 1996, 12:266-273
18. Overturf K, Al-Dhalimy M, Ou C-N, Finegold M, Grompe M: Serial transplantation reveals stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997, 151:1273-1280
19. Seglen PO: Preparation of isolated rat liver cells. Methods Cell Biol 1976, 13:29-83
20. Dabeva MD, Hwang S-G, Vasa SRG, Hurston E, Novikoff PM, Hixson DC, Gupta S, Shafritz DA: Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver. Proc Natl Acad Sci USA 1997, 94:7356-7361
21. Lillie RD (Ed): Histopathologic Technic and Practical Histochemistry. New York, McGraw-Hill, 1965, p 198
22. Peterson JE: Effects of the pyrrolizidine alkaloid lasiocarpine-N-oxide on nuclear and cell division in the liver of rats. J Pathol Bacteriol 1965, 89:153-171
23. Afzelius BA, Schoental RJ: The ultrastructure of the enlarged hepatocytes induced in rats with a single oral dose of retrorsine, a pyrrolizidine (Senecio) alkaloid. Ultrastruct Res 1967, 20:328-345
24. Jago MV: The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Am J Pathol 1969, 56:405-422
25. Samuel A, Jago MV: Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine, and of its metabolite, dehydroheliotridine. Chem Biol Interact 1975, 10:185-197
26. McLean E: The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacol Rev 1970, 22:429-483
27. Mattocks AR: Chemistry and Toxicology of Pyrrolizidine Alkaloids. Orlando, FL, Academic Press, 1986
28. Thompson NL, Hixson DC, Callavan H, Panzica M, Flanagan D, Faris RA, Hong W, Hartel-Schenk S, Doyle D: A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein: use as a liver-cell transplantation model. Biochem J 1991, 273:497-502
29. Gossrau R: Peptidasen II: zur lokalization der dipeptidylpeptidase IV (DPPIV). Histochemistry 1979, 60:231-248
30. Hubbard AL, Bartles JR, Braiterman LT: Identification of rat hepatocyte plasma membrane proteins using monoclonal antibodies. J Cell Biol 1985, 100:1115-1125
31. Walborg EF Jr, Tsuchida S, Weeden DS, Thomas MW, Barrick M, McEntire KO, Allison JP, Hixson DC. Identification of dipeptidylpeptidase IV as a protein shared by the plasma membrane of hepatocytes and liver biomatrix. Exp Cell Res 1985, 158:509-518
32. Wachstein M, Meisel E: Histochemistry of hepatic phosphastases at a physiologic pH. Am J Clin Pathol 1955, 27:13-23
33. Gupta S, Rajvanshi P, Lee C-D: Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidylpeptidase IV-deficient rats. Proc Natl Acad Sci USA 1995, 92:5860-5864
34. Hayes MA, Roberts E, Farber E: Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasio-carpine and senecionine. Cancer Res 1985, 45:3726-3734
35. Laconi E, Sarma DSR, Pani P: Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 1995, 16:139-142
36. Kay MA, Woo SLC: Gene therapy for metabolic disorders. Trends Genet 1994, 10:253-257